Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha.
about
The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review)NF-kappaB: a multifaceted transcription factor regulated at several levelsPost-translational modification of nuclear co-repressor receptor-interacting protein 140 by acetylationShort-chain fatty acid mediated phosphorylation of heat shock protein 25: effects on camptothecin-induced apoptosis.Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral ReservoirsNF-kappaB-dependent induction of cathelicidin-related antimicrobial peptide in murine mast cells by lipopolysaccharideHistone deacetylase inhibitors activate NF-kappaB in human leukemia cells through an ATM/NEMO-related pathwayBlockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation.Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaBModulation of acetylation: creating a pro-survival and anti-inflammatory phenotype in lethal hemorrhagic and septic shock.Spermidine/Spermine N1-Acetyltransferase 2 (SSAT2) functions as a coactivator for NF-kappaB and cooperates with CBP and P/CAF to enhance NF-kappaB-dependent transcription.TGF-beta induces p65 acetylation to enhance bacteria-induced NF-kappaB activation.PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation.NF-kappa B-mediated adaptive resistance to ionizing radiation.Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer.Creating a pro-survival and anti-inflammatory phenotype by modulation of acetylation in models of hemorrhagic and septic shock.HIV-1 transcription and latency: an update.The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation.TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs.Class II-specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL-8 expression in human melanoma cells.Anti-inflammatory properties of dairy lactobacilli.The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells.Identification of PP2A as a crucial regulator of the NF-kappaB feedback loop: its inhibition by UVB turns NF-kappaB into a pro-apoptotic factor.The house dust mite allergen Der p 1, unlike Der p 3, stimulates the expression of interleukin-8 in human airway epithelial cells via a proteinase-activated receptor-2-independent mechanism.Deacetylase inhibitors and the viral transactivator TaxBLV synergistically activate bovine leukemia virus gene expression via a cAMP-responsive element- and cAMP-responsive element-binding protein-dependent mechanism.Identification of NF-κB modulation capabilities within human intestinal commensal bacteria.Regulation of monocarboxylate transporter 1 (MCT1) promoter by butyrate in human intestinal epithelial cells: involvement of NF-kappaB pathway.Histone deacetylase inhibitors block nuclear factor-κB-dependent transcription by interfering with RNA polymerase II recruitment.Short-chain fatty acids stimulate the migration of neutrophils to inflammatory sites.Epigenetic modulation of chronic anxiety and pain by histone deacetylation.Combination Therapies Targeting HDAC and IKK in Solid Tumors.Negative regulation of the RelA/p65 transactivation function by the product of the DEK proto-oncogene.Epigenetic Regulation via Altered Histone Acetylation Results in Suppression of Mast Cell Function and Mast Cell-Mediated Food Allergic Responses
P2860
Q26799398-A846FB43-8B3F-4AC9-969F-E5D50DF1DA32Q28285466-48E87BC2-4FC0-485B-BC82-985F45E17CB0Q28589752-DEEBD2C5-BBF4-4E69-886E-A45E03AD6E4DQ33233579-14C1D0A6-BD65-489C-8983-078BF05AE7EEQ33476165-1240AEED-795B-4292-ACBE-CCFFF77FC4F0Q33613493-16285841-23FF-4FDA-9CF5-8241CBD06DD0Q33621811-1BD901BC-929F-430D-97C8-F5843A62697BQ33744417-54076C41-AD20-49F2-9755-E13771F59DCBQ33863049-ECA33484-EAAD-4419-8287-71692B987894Q34482017-4303C95C-64B3-4B94-B659-E81E6B4B97A3Q34635234-61D38012-C97A-4BBF-AFC7-BD23577CD20DQ35691440-6069432F-0B4A-464E-A5C6-8864551A66D3Q35752922-12AC9801-C744-4014-B8B4-A445DA21467CQ36402780-98D17B0C-BCA3-471D-8A6E-25E3582D3FF9Q36493029-18F1D940-F4D6-4E7F-8779-8F08E9F17150Q36525896-877BDD41-BC6A-4ECB-BB81-C3E26A69A25FQ36698389-FD892FBA-D28E-4A52-9465-D3FA602FBB40Q36972324-8C166D59-58B4-42EA-846B-AC95FAB9FC96Q36976156-A834A1A6-E4D8-4E64-9B21-732AECA804E6Q37085681-CBA2E886-D73C-4D5C-9416-D260E2649CFBQ37433321-BF37340D-5B87-4A6F-966F-5ED5933F324FQ37644561-D1A33C98-4035-425B-B0DC-849BA0D5B3B4Q37747368-49C6A898-BEB7-4C13-914A-1B1C58AD6B44Q39240051-05B737A2-EA54-42D5-B2BD-9A8D8DE3A806Q39491174-602D3743-1680-4678-B4A4-D1C59755B31CQ39925879-B16A9B54-7A96-4CB1-893A-408AD33EA171Q39967736-1FD8EFD5-312E-4AC2-9BC1-34ED78489904Q40350258-E4C24C7A-840C-4C9C-8E2D-CBE63A72108BQ40551632-263EA6A7-5AB8-42CE-BAE8-3A19441E3978Q41907716-FA6C8984-D150-4267-ABD3-CAFC1F4A8254Q43140940-F002B2D3-D40F-41B0-BEA4-19580407098AQ45820993-6991B449-B118-4AA9-90F2-B4C933C1F25FQ46067229-3218B1C3-C6CB-4D0D-95A8-B996401CB1F3Q48494798-C4BE0C18-8901-4C1F-AC79-EB2F65F5D700Q49887757-899FECD3-1D60-43ED-82DD-D8328129FBBFQ51584941-63BB0145-970C-42D8-9741-B749A2E92307Q58572698-4D882BE5-6351-49D6-9517-0443E3377398
P2860
Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Potentiation of tumor necrosis ...... appearance of I kappa B alpha.
@ast
Potentiation of tumor necrosis ...... appearance of I kappa B alpha.
@en
type
label
Potentiation of tumor necrosis ...... appearance of I kappa B alpha.
@ast
Potentiation of tumor necrosis ...... appearance of I kappa B alpha.
@en
prefLabel
Potentiation of tumor necrosis ...... appearance of I kappa B alpha.
@ast
Potentiation of tumor necrosis ...... appearance of I kappa B alpha.
@en
P2093
P2860
P50
P1476
Potentiation of tumor necrosis ...... appearance of I kappa B alpha.
@en
P2093
Alain Chariot
Caroline Vanhulle
Emmanuelle Adam
Françoise Bex
Geoffrey Gloire
Géraldine Carrard
Jacques Piette
Sonia Schoonbroodt
Thi Liên-Anh Nguyên
Vincent Quivy
P2860
P304
P356
10.1128/MCB.23.17.6200-6209.2003
P407
P50
P577
2003-09-01T00:00:00Z